Showing results (251-260 of 390) with videos related to

Sort By:
Pageof 39
Scandinavian Journal of Rheumatology|January 1, 1996
Embolization of multiple pulmonary arterial aneurysms in Behçet's diseaseH Mouas, O Lortholary, P Lacombe, et al.
Annals of the Rheumatic Diseases|November 16, 2001
Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosusV Noël, O Lortholary, P Casassus, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 2001
[Valvular locations in Whipple's disease: report of two cases and review of the literature]J C Charniot, L Mouthon, A Martin, et al.
Rheumatology (Oxford, England)|April 24, 2003
Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control studyA Eden, A Mahr, A Servant, et al.
Annales De Medecine Interne|January 1, 1986
[Treatment of systemic scleroderma with ketanserin. Randomized, double-blind 6-months study of 27 cases]J Cadranel, O Blétry, L Guillevin, et al.
Annales De Medecine Interne|July 18, 2000
[Evolution of polyvalent intravenous immunoglobulins (IVIg) prescription, at the Assistance Publique - Hopitaux de Paris between 1988 and 1997. Results of the plan of action set up in order to regulate the prescription]A Courtay, I Couturon, E Charpentier, et al.
Arthritis and Rheumatism|August 1, 1993
The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluationR Gherardi, L Belec, C Mhiri, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1996
Relationship between sex steroid hormone levels and CD4 lymphocytes in HIV infected menN Christeff, O Lortholary, P Casassus, et al.
La Nouvelle Presse Medicale|February 28, 1981
[Value of plasma exchange in the management of acute immunoallergic thrombocytopenic purpura (author's transl)]R Zittoun, S Bergeret, S Thierry, et al.
Cancer|February 1, 1976
Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignanciesC Jacquillat, M Weil, M F Gemon-Auclerc, et al.
Pageof 39